Healthcare Leadership Council

Quality, Competition, Innovation

The Healthcare Leadership Council (HLC), a coalition of chief executives from all disciplines within American healthcare, is the exclusive forum for the nation’s healthcare leaders to jointly develop policies, plans, and programs to achieve their vision of a 21st century system that makes affordable, high-quality care accessible to all Americans.

What's Happening in Healthcare

New Campaign Will Spotlight Successes of Medicare Advantage

The Better Medicare Alliance (BMA), ( the leading advocacy coalition supporting Medicare Advantage, has announced the launch of “Medicare Advantage: The Facts Say Yes”, a digital advocacy campaign on the success of the Medicare Advantage in improving care for seniors and people with disabilities.

The Healthcare Leadership Council is a charter member of the Better Medicare Alliance.

From better use of primary care to preventive care and enhanced benefits, Medicare Advantage is improving health care for over 17 million beneficiaries – and the facts show it. As part of the campaign, BMA published an online microsite linking to fact sheets that highlight the latest research and data on delivery of care for Medicare Advantage beneficiaries. More Details »

Congressional Spending, Tax Extender Package Includes Major Positives for Patients, Healthcare System

WASHINGTON – A package of spending measures and tax extenders announced by congressional leaders last night contains provisions that will strengthen healthcare innovation and benefit patients and the healthcare system as a whole, the president of the Healthcare Leadership Council said today.

HLC president Mary R. Grealy praised Capitol Hill negotiators for taking steps that will enable financial resources to be better used to improve healthcare quality for patients and consumers.  She mentioned, specifically:

  • The two-year moratorium on the Affordable Care Act’s tax on medical devices and a one-year moratorium on the ACA’s health insurance excise tax.

“These steps continue to bolster optimism that Congress can make positive, productive changes to the Affordable Care Act, just as it did with the earlier PACE Act to make health insurance more affordable for small employers,” Ms. Grealy said.  More Details »

Statement by Mary R. Grealy, President, Healthcare Leadership Council on Prescription Drug Importation Legislation in the U.S. Senate

Proponents of prescription drug importation paint the concept as a panacea that would provide access to low-cost medications. The truth is more complex and more perilous for patients, consumers and the future development of new cures and improved treatments.

The prevalence of counterfeit and improperly altered drugs is a very real global problem. The World Health Organization has estimated that 10 percent of the medications on the worldwide market are counterfeits. Americans have died as a result of these fake medicines. The U.S. Food and Drug Administration works diligently and effectively to ensure that the prescription drugs on which millions rely are safe and effective. It may seem a benign step to allow drugs from Canada to flow into our country, but because we can’t oversee the sourcing of drugs attained by Canadian pharmacies, importation legislation would make it more difficult for the FDA and law enforcement authorities to protect consumer health.

More Details »

More Stories »